References and Notes
- 1
Gnad F.
Reiser O.
Chem. Rev.
2003,
103:
1603
-
2a
Reissig HU.
Zimmer R.
Chem. Rev.
2003,
103:
1151
-
2b
Reissig HU.
Top. Curr. Chem.
1988,
144:
73
-
2c
Yu M.
Pagenkopf BL.
Tetrahedron
2005,
61:
321
-
3a
Horikawa H.
Nishitani T.
Iwasaki T.
Inoue I.
Tetrahedron Lett.
1983,
24:
2193
-
3b
El Abdioui K.
Martinez J.
Viallefont P.
Vidal Y.
Bull. Soc. Chim. Belg.
1997,
106:
425
-
3c
Papageorgiou CD.
Cubillo de Dios MA.
Ley SV.
Gaunt MJ.
Angew. Chem. Int. Ed.
2004,
43:
4641
-
3d
Adams LA.
Charmant JPH.
Cox RJ.
Walter M.
Whittingham WG.
Org. Biomol. Chem.
2004,
2:
542
-
3e
Adams LA.
Cox RJ.
Gibson JS.
Mayo-Martín MB.
Walter M.
Whittingham W.
Chem. Commun.
2002,
2004
-
3f
Jiménez JM.
Rifé J.
Ortuño RM.
Tetrahedron: Asymmetry
1995,
6:
1849
-
3g
Jiménez JM.
Rifé J.
Ortuño RM.
Tetrahedron: Asymmetry
1996,
7:
537
-
3h
Yamazaki S.
Inoue T.
Hamada T.
Takada T.
Yamamoto K.
J. Org. Chem.
1999,
64:
282
-
3i
Wick L.
Tamm C.
Boller T.
Helv. Chim. Acta
1995,
78:
403
-
4a
Bubert C.
Voigt J.
Biasetton S.
Reiser O.
Synlett
1994,
675
-
4b
Bubert C.
Cabrele C.
Reiser O.
Synlett
1997,
827
-
4c
Maas G.
Müller A.
J. Prakt. Chem.
1998,
340:
315
-
5a
Geen GR.
Kincey PM.
Choudary BM.
Tetrahedron Lett.
1992,
33:
4609
-
5b
Geen GR.
Harnden MR.
Parratt MJ.
Bioorg. Med. Chem. Lett.
1991,
1:
347
-
5c Geen GR, Grinter TJ, and Moore S. inventors; Eur. Pat. Appl. EP 420559.
; Chem. Abstr. 1991, 115, 28993
-
5d Hayashi T, Yasuoka J, and Nishikawa J. inventors; Jpn. Kokai Tokkyo Koho JP 2000327593.
; Chem. Abstr. 2000, 133, 362933
-
5e Hayashi T, Yasuoka J, and Nishiura A. inventors; Eur. Pat. Appl. EP 916674.
; Chem. Abstr. 1999, 131, 5268
-
5f
Kim HS.
Barak D.
Harden TK.
Boyer JL.
Jacobson KA.
J. Med. Chem.
2001,
44:
3092
- 6
Su Q.
Wood JL.
Synth. Commun.
2000,
30:
3383
-
7a
Trukhin EV.
Makarenko SV.
Berestovitskaya VM.
Russ. J. Org. Chem.
1998,
34:
59 ; Chem. Abstr. 1998, 130, 3661
-
7b
Villemin D.
Thibault-Starzyk F.
Hachemi M.
Synth. Commun.
1994,
24:
1425
-
7c
Le Menn JC.
Tallec A.
Sarrazin J.
Can. J. Chem.
1991,
69:
761
-
7d
Sopova AS.
Bakova OV.
Metelkina EL.
Perekalin VV.
Zh. Org. Khim.
1975,
11:
68 ; Chem. Abstr. 1975, 83, 9406
-
7e
Sopova AS.
Yurchenko OI.
Perekalin VV.
Zh. Obshch. Khim.
1965,
1:
1707 ; Chem. Abstr. 1966, 64, 3726
-
7f
Kohler EP.
Darling SF.
J. Am. Chem. Soc.
1930,
52:
424
-
8a
Smirnov VO.
Tishkov AA.
Lyapkalo IM.
Ioffe SL.
Kachala VV.
Strelenko YA.
Tartakovsky VA.
Russ. Chem. Bull.
2001,
50:
2433 ; Chem. Abstr. 2002, 137, 279247
-
8b
Danilenko VM.
Tishkov AA.
Ioffe SL.
Lyapkalo IM.
Strelenko YA.
Tartakovsky VA.
Synthesis
2002,
635
-
8c
Tishkov AA.
Kozintsev AV.
Lyapkalo IM.
Ioffe SL.
Kachala VV.
Strelenko YA.
Tartakovsky VA.
Tetrahedron Lett.
1999,
40:
5075
- 9
Mangelinckx S.
De Kimpe N.
Synlett
2005,
1521
- 10
Harnisch J.
Szeimies G.
Chem. Ber.
1979,
112:
3914
- 11
Su J.
Qiu G.
Liang S.
Hu X.
Synth. Commun.
2005,
35:
1427
- 13
Verhé R.
De Kimpe N.
De Buyck L.
Courtheyn D.
Schamp N.
Bull. Soc. Chim. Belg.
1978,
87:
215
-
14a
Murahashi SI.
Taniguchi Y.
Imada Y.
Tanigawa Y.
J. Org. Chem.
1989,
54:
3292
-
14b
Hoffman RV.
Severns BS.
J. Org. Chem.
1996,
61:
5567
- 16
Sunitha K.
Balasubramanian KK.
Tetrahedron
1987,
43:
3269
- 17
Graziano ML.
Scarpati R.
J. Chem. Soc., Perkin Trans. 1
1985,
289
-
18a
Doyle MP.
van Leusen D.
J. Org. Chem.
1982,
47:
5326
-
18b
Reissig HU.
Tetrahedron Lett.
1985,
26:
3943
-
19a
Saito S.
Nakajima H.
Inaba M.
Moriwake T.
Tetrahedron Lett.
1989,
30:
837
-
19b
Woltering TJ.
Weitz-Schmidt G.
Wong C.-H.
Tetrahedron Lett.
1996,
37:
9033
- 20
von Angerer S.
Carbocyclic Three-Membered Ring Compounds, In Houben-Weyl
Vol. E 17c:
de Meijere A.
Thieme;
Stuttgart:
1997.
p.2121-2123
- 21
Rosen T.
Lico JM.
Chu DTW.
J. Org. Chem.
1988,
53:
1580
- 22
Barua A.
Bez G.
Barua NC.
Synlett
1999,
553
-
23a
Afonso CAM.
Tetrahedron Lett.
1995,
36:
8857
-
23b
Ariza X.
Urpi F.
Viladomat C.
Vilarrasa J.
Tetrahedron Lett.
1998,
39:
9101
- 24
Nyffeler PT.
Liang C.-H.
Koeller KM.
Wong C.-H.
J. Am. Chem. Soc.
2002,
124:
10773
- 25
Hemming K.
Bevan MJ.
Loukou C.
Patel SD.
Renaudeau D.
Synlett
2000,
1565
- 27 For a recent review on the intramolecular reaction of iminophosphoranes with esters see: Fresneda PM.
Molina P.
Synlett
2004,
1
- 28
Quin LDA.
A Guide to Organophosphorus Chemistry
Wiley;
New York:
2000.
-
29a
Lin FL.
Hoyt HM.
van Halbeek H.
Bergman RG.
Bertozzi CR.
J. Am. Chem. Soc.
2005,
127:
2686
-
29b
Shalev DE.
Chiacchiera SM.
Radkowsky AE.
Kosower EM.
J. Org. Chem.
1996,
61:
1689
-
30a
Barluenga J.
Ferrero M.
Palacios F.
J. Chem. Soc., Perkin Trans. 1
1990,
2193
-
30b
Palacios F.
Ochoa de Retana AM.
Pagalday J.
Eur. J. Org. Chem.
2003,
913
-
32a
Leguern D.
Le Moing MA.
Morel G.
Foucaud A.
Tetrahedron
1977,
33:
27
-
32b
Leguern D.
Morel G.
Foucaud A.
Tetrahedron Lett.
1974,
15:
955
- 33
Neidlein R.
Shatzmiller S.
Sinnreich D.
Liebigs Ann. Chem.
1983,
8
- 34
Graziano ML.
Iesce MR.
J. Chem. Res., Synop.
1987,
362
- 35
Kolsaker P.
Jensen AK.
Acta Chem. Scand., Ser. B
1988,
42:
345
- 36
Takeda A.
Tsuboi S.
Oota Y.
J. Org. Chem.
1973,
38:
4148
12
General Procedure for the Synthesis of 3-Azido-2,2-dialkyl-1,1-dicarboxylates 9.
To a solution of 2-bromoalkylidenemalonate 8
13 (5 mmol) in MeOH (5 mL) (or EtOH for 9b) was added NaN3 (6 mmol). The reaction mixture was stirred at reflux for 14-16 h. The reaction mixture was then evaporated, diluted with dry Et2O, filtered and concentrated. The pure cyclopropanes 9a-c, γ-azido-α,β-unsaturated diesters 10a,b and olefin 11
13 were obtained by column chromatography (silica gel, PE-EtOAc, 4:1) for 9a and 10a; (silica gel, PE-Et2O, 9:1) for 9b and 10b; (silica gel, hexane-Et2O, 95:5) for 9c and 11.
Cyclopropanes 9a,b and γ-azido-α,β-unsaturated diesters 10a,b are reported as representative examples.
Dimethyl 3-Azido-2,2-dimethylcyclopropane-1,1-dicarboxylate (9a): colourless oil. R
f
= 0.47 (PE-EtOAc, 4:1). 1H NMR (270 MHz, CDCl3): δ = 1.24 (s, 3 H), 1.26 (s, 3 H), 3.70 (s, 1 H), 3.75 (s, 3 H), 3.79 (s, 3 H). 13C NMR (68 MHz, CDCl3): δ = 17.9, 19.6, 31.1, 42.3, 51.9, 52.5, 52.9, 165.8, 167.7. IR (NaCl): ν = 2113, 1732 cm-1. MS (ES, pos. mode): m/z (%) = 200(19) [M - N2 + H+], 173 (100) [M - CHN3 + H+]. Anal. Calcd for C9H13N3O4: C, 47.57; H, 5.77; N, 18.49. Found: C, 47.32; H, 5.69; N, 18.65.
Dimethyl (2-Azido-2-methylpropylidene)malonate (10a): colourless oil. R
f
= 0.32 (PE-EtOAc, 4:1). 1H NMR (270 MHz, CDCl3): δ = 1.49 (s, 6 H), 3.80 (s, 3 H), 3.87 (s, 3 H), 6.80 (s, 1 H). 13C NMR (68 MHz, CDCl3): δ = 26.5, 52.6, 52.8, 60.7, 127.2, 148.0, 164.0, 166.2. IR (NaCl): ν = 2110, 1737, 1654 cm-1. MS (EI, 70 eV): m/z (%) = no [M+], 196 (2), 185 (59), 184 (10), 168 (3), 154 (5), 153 (53), 125 (10), 124 (11), 88 (11), 86 (73), 84 (100), 59 (10). Anal. Calcd for C9H13N3O4: N, 18.49. Found: N, 18.21.
Diethyl 3-Azido-2,2-dimethylcyclopropane-1,1-dicarboxylate (9b): colourless oil. R
f
= 0.39 (PE-Et2O, 4:1). The 1H NMR and 13C NMR data are in good agreement with reported data, with the exception that in the 1H NMR the signals at δ = 1.23 and 1.27 ppm are two times a singlet and not doublet of doublet, and in the 13C NMR, the signals for CHN3 (δ = 51.6 ppm) and CMe2 (δ = 30.7 ppm) were mistakenly attributed.11 1H NMR (300 MHz, CDCl3): δ = 1.23 (s, 3 H), 1.27 (s, 3 H), 1.27 (t, J = 7.15 Hz, 3 H), 1.31 (t, J = 7.15 Hz, 3 H), 3.68 (s, 1 H), 4.11-4.31 (m, 4 H). 13C NMR (75 MHz, CDCl3): δ = 14.1, 17.9, 19.6, 30.7, 42.8, 51.6, 61.4, 61.9, 165.2, 167.4. IR (NaCl): ν = 2112, 1729 cm-1. MS (ES, pos. mode): m/z (%) = 228 (17) [M - N2 + H+], 201 (100) [M - CHN3 + H+]. Anal. Calcd for C11H17N3O4: C, 51.76; H, 6.71; N, 16.46. Found C, 51.46; H, 6.65; N, 16.33.
Diethyl (2-Azido-2-methylpropylidene)malonate (10b): colourless oil. R
f
= 0.20 (PE-Et2O, 4:1). 1H NMR (300 MHz, CDCl3): δ = 1.30 (t, J = 7.15 Hz, 3 H), 1.36 (t, J = 7.15 Hz, 3 H), 1.49 (s, 6 H), 4.25 (q, J = 7.15 Hz, 2 H), 4.34 (q, J = 7.15 Hz, 2 H), 6.76 (s, 1 H). 13C NMR (75 MHz, CDCl3): δ = 13.97, 14.05, 26.6, 60.7, 61.7, 61.9, 128.0, 147.2, 163.6, 165.7. IR (NaCl): ν = 2111, 1735, 1655 cm-1. MS (ES, pos. mode): m/z (%) = 228 (52) [M - N2 + H+], 213 (100). Anal. Calcd for C11H17N3O4: C, 51.76; H, 6.71; N, 16.46. Found: C, 51.53; H, 6.63; N, 16.38.
15
Methyl 4-Azidobut-3-enoate (13): colourless oil. R
f
= 0.37 (PE-EtOAc, 4:1). 1H NMR (300 MHz, CDCl3): δ
(Z-isomer) = 3.14 (dd, J = 7.15 Hz, J = 1.65 Hz, 2 H), 3.70 (s, 3 H), 5.06 (dt, J = 7.43 Hz, J = 7.15 Hz, 1 H), 6.32 (dt, J = 7.43 Hz, J = 1.65 Hz, 1 H); δ (E-isomer) = 3.07 (dd, J = 7.43 Hz, J = 1.38 Hz, 2 H), 3.70 (s, 3 H), 5.45 (dt, J = 13.76 Hz, J = 7.43 Hz, 1 H), 6.03 (dt, J = 13.76 Hz, J = 1.38 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ
(Z-isomer) = 31.0, 52.0, 111.4, 128.3, 171.6; δ (E-isomer) = 34.5, 52.1, 111.8, 129.9, 171.6. IR (NaCl): ν = 2111, 1739, 1648 cm-1. MS (ES, pos. mode): m/z (%) = 283 (100)
[2 M + H+]. Anal. Calcd for C5H7N3O2: C, 42.55; H, 5.00; N, 29.77. Found: C, 42.35; H, 5.15; N, 29.63.
26
General Procedure for the Synthesis of Alkyl 5-Alkoxy-4,4-dialkyl-2-oxopyrrolidine-3-carboxylates (15).
To a solution of azidocyclopropane 9 (1 mmol) in dry THF (4 mL) under nitrogen atmosphere was added Ph3P (0.275 g, 1.05 mmol). The reaction mixture was stirred for 3 h at r.t. The reaction mixture was poured into H2O (10 mL) and extracted with CH2Cl2. After drying of the organic layer (MgSO4), filtration and evaporation, the pure pyrrolidin-2-ones 15 were obtained as diastereomeric mixtures after column chromatography (silica gel, PE-EtOAc).
Pyrrolidinone 15a is reported as a representative example.
Methyl 5-Methoxy-4,4-dimethyl-2-oxopyrrolidine-3-carboxylate (15a): amorphous white solid. R
f
= 0.29 and 0.22 (PE-EtOAc, 1:3). Mp 73.8-74.7 °C. Spectral data obtained from the mixture of two isomers (ratio 4:1). 1H NMR (300 MHz, CDCl3): δ = 1.09 (s, 3 H), 1.25 (s, 3 H), 2.98 (s, 1/5 H), 3.34 (s, 12/5 H), 3.36 (s, 3/5 H), 3.37 (s, 4/5 H), 3.73 (s, 3/5 H), 3.76 (s, 12/5 H), 4.31 (d, J = 1.24 Hz, 4/5 H), 4.33 (d, J = 1.10 Hz, 1/5 H), 8.62 (br s, 4/5 H), 8.67 (br s, 1/5 H). 13C NMR (75 MHz, CDCl3): δ (for the major isomer) = 22.1, 23.5, 44.2, 52.1, 55.9, 56.7, 93.2, 168.8, 174.4; δ (for the minor isomer) = 19.1, 29.5, 43.3, 52.2, 56.1, 59.0, 94.0, 169.1, 174.7. IR (KBr): ν = 3218, 3116, 1733, 1698 cm-1. LCMS (ES, pos. mode): m/z (for the major isomer, %) = 425 (7) [2 M + Na+], 202 (100) [M + H+]; m/z (for the minor isomer, %) = 425 (7) [2 M + Na+], 170 (100) [M - MeOH + H+]. Anal. Calcd for C9H15NO4: C, 53.72; H, 7.51; N, 6.96. Found: C, 53.47; H, 7.58; N, 6.88.
31
5-Methoxy-3-(methoxycarbonyl)-4,4-dimethyl-1-(triphenylphosphonio)-4,5-dihydro-1
H
-pyrrol-2-olate (20a): hygroscopic white crystals; mp 76.5-78.0 °C. 1H NMR (300 MHz, CDCl3): δ = 1.32 (s, 3 H), 1.46 (s, 3 H), 2.65 (s, 3 H), 3.63 (s, 3 H), 3.87 (s, 1 H), 7.50-7.80 (m, 15 H). 13C NMR (75 MHz, CDCl3): δ = 20.4, 28.5, 46.5 (d, 3
J
P,C = 9.2 Hz), 49.4, 56.5, 79.9 (d, 3
J
P,C = 8.1 Hz), 97.0 (d, 2
J
P,C = 3.5 Hz), 122.3 (d, 1
J
P,C = 105.0 Hz), 129.4 (d, 3
J
P,C = 13.9 Hz), 133.9 (d, 4
J
P,C = 2.3 Hz), 134.1 (d, 2
J
P,C = 11.5 Hz), 165.5, 167.6. 31P NMR (121 MHz, CDCl3): δ = 34.8. IR (KBr): ν = 1667, 1615 cm-1. MS (ES, pos. mode): m/z (%) = 462 (100) [M + H+].